SEC CIK 1012990
TAMBAKERAS MARKOS I
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| KMTview stock → | 218,523.95 | 2006-11-29 |
| ITTview stock → | 13,207 | 2012-11-09 |
| PHview stock → | 13,041 | 2011-02-10 |
| XYLview stock → | 3,140 | 2022-05-12 |
Position History — XYL
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — XYL
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2022-05-12 | Grant / award | 1,812 | $0.00 | 3,140 |
| 2021-09-13 | Open-market sale | 5,000 | $131.96 | 25,062 |
| 2021-06-01 | Open-market sale | 3,000 | $119.12 | 30,062 |
| 2021-05-12 | Grant / award | 1,328 | $0.00 | 44,575 |
| 2021-03-15 | Open-market sale | 5,000 | $102.02 | 33,062 |
| 2020-12-15 | Open-market sale | 5,000 | $99.00 | 38,062 |
| 2020-10-16 | Gift | 6,777 | $0.00 | 0 |
| 2020-10-05 | Open-market sale | 6,050 | $85.23 | 36,285 |
| 2020-10-02 | Open-market sale | 700 | $85.00 | 42,335 |
| 2020-08-11 | Open-market sale | 14,000 | $80.20 | 43,035 |
| 2020-08-10 | Open-market sale | 5,000 | $77.54 | 57,035 |
| 2020-05-13 | Grant / award | 2,577 | $0.00 | 43,247 |
| 2019-11-05 | Option exercise (derivative) | 2,860 | $0.00 | 0 |
| 2019-11-05 | Open-market sale | 2,860 | $78.95 | 40,670 |
| 2019-11-05 | Option exercise | 2,860 | $30.03 | 43,530 |
| 2019-05-15 | Grant / award | 2,714 | $0.00 | 40,670 |
| 2018-05-09 | Grant / award | 2,886 | $0.00 | 37,956 |
| 2017-05-10 | Grant / award | 4,065 | $0.00 | 44,582 |
| 2016-05-11 | Grant / award | 4,373 | $0.00 | 40,517 |
| 2015-11-12 | Option exercise (derivative) | 3,970 | $0.00 | 0 |
| 2015-11-12 | Option exercise | 3,970 | $18.63 | 38,169 |
| 2015-11-12 | Open-market sale | 2,025 | $36.73 | 36,144 |
| 2015-05-12 | Grant / award | 5,139 | $0.00 | 34,199 |
| 2015-03-02 | Option exercise (derivative) | 2,960 | $0.00 | 0 |
| 2015-03-02 | Option exercise | 2,960 | $29.81 | 31,514 |
| 2015-03-02 | Open-market sale | 2,454 | $36.16 | 29,060 |
| 2014-05-06 | Grant / award | 5,077 | $0.00 | 28,554 |
| 2014-02-11 | Option exercise (derivative) | 2,700 | $0.00 | 0 |
| 2014-02-11 | Open-market sale | 2,373 | $37.23 | 23,477 |
| 2014-02-11 | Option exercise | 2,700 | $32.56 | 25,850 |
| 2013-11-12 | Option exercise (derivative) | 2,480 | $0.00 | 0 |
| 2013-11-12 | Open-market sale | 1,551 | $33.83 | 23,150 |
| 2013-11-12 | Option exercise | 2,480 | $21.03 | 24,701 |
| 2013-05-07 | Grant / award | 5,509 | $0.00 | 22,221 |
| 2012-11-09 | Option exercise (derivative) | 2,420 | $0.00 | 0 |
| 2012-11-09 | Open-market sale | 1,712 | $24.73 | 16,712 |
| 2012-11-09 | Option exercise | 2,420 | $17.35 | 18,424 |
| 2012-05-10 | Grant / award | 5,834 | $0.00 | 12,444 |
| 2012-03-01 | Option exercise (derivative) | 2,140 | $0.00 | 0 |
| 2012-03-01 | Option exercise | 2,140 | $25.53 | 6,610 |
| 2012-03-01 | Option exercise (derivative) | 3,560 | $0.00 | 0 |
| 2012-03-01 | Option exercise | 3,560 | $19.40 | 10,170 |
| 2011-11-07 | Grant / award | 3,101 | $0.00 | 4,470 |
| 2011-11-01 | Grant / award (derivative) | 2,960 | $0.00 | 2,960 |
| 2011-11-01 | Grant / award (derivative) | 2,700 | $0.00 | 2,700 |
| 2011-11-01 | Grant / award (derivative) | 3,040 | $0.00 | 3,040 |
| 2011-11-01 | Grant / award (derivative) | 2,140 | $0.00 | 2,140 |
| 2011-11-01 | Grant / award (derivative) | 2,480 | $0.00 | 2,480 |
| 2011-11-01 | Grant / award (derivative) | 2,420 | $0.00 | 2,420 |
| 2011-11-01 | Grant / award (derivative) | 3,560 | $0.00 | 3,560 |
| 2011-11-01 | Grant / award (derivative) | 2,860 | $0.00 | 2,860 |
| 2011-11-01 | Grant / award (derivative) | 3,970 | $0.00 | 3,970 |
| 2011-10-31 | — | — | — | 1,369 |
| 2011-10-31 | — | — | — | 17,595 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.